BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 10191767)

  • 1. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
    Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
    Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
    Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
    Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
    Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
    Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
    Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
    Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma.
    Kilo MN; Dorfman DM
    Am J Clin Pathol; 1996 Apr; 105(4):451-7. PubMed ID: 8604687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma.
    Jevremovic D; Dronca RS; Morice WG; McPhail ED; Kurtin PJ; Zent CS; Hanson CA
    Leuk Res; 2010 Sep; 34(9):1235-8. PubMed ID: 20362334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
    Kroft SH; Dawson DB; McKenna RW
    Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
    Dunphy CH; Perkins SL
    Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
    Sorigue M; Junca J; Ferra C; Marce S; Ruiz-Xivillé N; Pinyol L; Cabezon M; Espasa A; Dominguez D; Lopez-Viaplana L; Ruiz R; Buch J; Plensa E; Mostacedo SZ; Aranda J; Vergara S; Raya M; Granada I; Tapia G; Navarro JT; Beà S; Zamora L
    Cytometry B Clin Cytom; 2020 Sep; 98(5):421-428. PubMed ID: 32530577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
    Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
    Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
    Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
    Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathologic characteristics of bone marrow for 
CD5 positive small B cell lymphoma].
    Peng S; Zhu F; You S; Gong M; Wen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):374-9. PubMed ID: 27241147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
    Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S35-41. PubMed ID: 20568273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5-negative phenotype of monoclonal B-lymphocytosis of undetermined significance (MLUS).
    Wang C; Amato D; Fernandes B
    Am J Hematol; 2002 Feb; 69(2):147-9. PubMed ID: 11835355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.